Robert F. Kennedy

Aug. 20 (UPI) — President Donald Trump has nominated White House aide Dr. Heidi Overton to lead the Food and Drug Administration, drawing anger from Democrats and criticism from a key Republican senator.

Trump announced his nomination of Overton to be the next FDA commissioner on his Truth Social platform Wednesday, calling the deputy director of the White House Domestic Policy Council “a ROCKSTAR in my administration.”

“She is known to take on the HARDEST issues, and bring me solutions that work best for the Country,” Trump said. “We need her leadership at the FDA now to ensure that the U.S. remains the WORLD LEADER for Scientific Discovery and CURES.”

If confirmed by the Senate, Overton will be tasked with overseeing agency policy concerning drugs, vaccines, tobacco products and much of the food supply, among other responsibilities. Kyle Diamantas, a friend of Trump’s son Donald Trump Jr. has been serving as acting FDA commissioner since Marty Makary resigned as head of the agency in May following reported clashes with the Trump administration over its decision to authorize fruit-flavored electronic cigarettes.

“Heidi brings exceptional judgment, professionalism, discipline and an unwavering commitment to the American people,” Department of Health and Human Services Secretary Robert F. Kennedy Jr. said in a statement supporting her nomination to lead the FDA under him.

“I have seen her challenge assumptions, demand excellence and turn bold ideas into meaningful results.”

She has had an increasingly visible presence near the president in recent months and most recently appeared with him earlier this month when he signed an executive order to reduce the number of vaccines recommended for children, which has sparked widespread concern among the medical community.

House Speaker Mike Johnson, R-La., called Overton “a woman of deep faith, an accomplished physician and a champion of the America First agenda” as he congratulated her on the nomination.

“I have seen firsthand her ability to navigate complex policy challenges with conviction and clarity,” he said in a social media statement.

“She will serve our country well.”

While Republicans praised Trump’ pick, Sen. Bill Cassidy, a doctor, broke ranks, saying that while he respected her experience as a physician, “I have strong concerns about her nomination,” citing her lack of managerial experience of a large organization, such as the FDA, which is dealing with staffing and morale issues.

“Additionally, Dr. Overton’s active role in last week’s nonsensical vaccine executive order calls into question her commitment to standing up for sound science and protecting children’s health,” he said online.

“That alone is almost disqualifying.”

Cassidy, who represents Louisiana, will play a key roe in her confirmation as chairman of the Senate Health, Education Labor and Pensions Committee a key vote in whether she is confirmed. Republicans can afford to lose only three votes on the Senate floor, as they only hold a 53-seat majority. The two independent senators caucus with the Democrats, who are all expected to all vote against her nomination.

“Heidi Overton is a far-right, anti-abortion extremist who has no business leading the FDA,” Sen. Patty Murray, D-Wash., said in a statement.

“The American people deserve someone who will put science and facts FIRST, not another Trump sycophant who will make it their mission to attack medication abortion.

“I will vote NO.”

Reproductive health organizations also criticized Trump’s pick, pointing to Overton’s celebration of the overturning of Roe vs. Wade, returning oversight of abortion to the states, as a “huge victory” and to her advocacy for what they described as the politicization of government agencies when she worked at the far-right America First Policy Institute think tank.

“Donald Trump is trying to put an anti-abortion extremist in charge of any agency that could seriously undermine reproductive healthcare — including the agency that could roll back access to mifepristone nationwide,” Reproductive Freedom for All President and CEO Mini Timmaraju said in a statement, referring to a prescription oral medication used to terminate an early pregnancy.

“Her nomination is another alarming step in Trump’s plan to weaponize every part of the federal government to restrict abortion nationwide.”

Aug. 19 (UPI) — President Donald Trump is expected to nominate Dr. Heidi Overton, a White House policy aide, to lead the Food and Drug Administration.

The decision was reported by the Washington Post, The New York Times and Politico, all citing anonymous sources. Overton is an aide at the White House’s Domestic Policy Council and will be tapped to be the next FDA commissioner, sources say.

Overton will replace Marty Makary, who left the position in May, and the Senate will have to confirm her to the position.

The FDA commissioner is one of the most powerful jobs in U.S. health care. The FDA oversees drugs, vaccines, tobacco products, the bulk of the food supply and more. The position has remained open longer than expected as some have turned it down over fears of administration interference, the Post reported.

The position has been run by acting FDA Commissioner Kyle Diamantas, a friend of Donald Trump Jr., and a former partner at the law firm Jones Day.

Overton is board-certified in public health and general preventive medicine and was a general surgery resident at Johns Hopkins Hospital in Baltimore, where she also earned a doctorate in clinical investigation. She worked at the America First Policy Institute, a conservative think tank. She has also written articles calling abortion “corrosive” to women. She called abortion pills “far more dangerous to women” and has called for more controls on the pills.

In September, Secretary of Health and Human Services Robert F. Kennedy Jr. said Overton and Calley Means worked on a Make America Healthy Again strategy report calling for more review of chemicals in food and an increase in oversight over pharmaceutical advertisements, The Times reported.

Makary left the position in May because he disagreed with the administration’s policy of allowing tobacco and e-cigarette companies to sell flavored vapes. The White House had been pressuring Makary to allow the vapes, but he disagreed, citing their appeal to teens and young adults.

The FDA approved mango and blueberry vapes just after Trump had lunch with tobacco executives, The Times reported.

While she is a doctor and has been present for many FDA announcements at the White House, she hasn’t run a large agency before. The FDA has thousands of employees and shapes food safety and pharmaceutical policies.

1 of 3 | Health and Human Services Secretary Robert F. Kennedy Jr. speaks before President Donald Trump signs an executive order that reevaluates childhood vaccines in the Oval Office of the White House in Washington, D.C., on Monday. While the executive order still recommends childhood vaccines for 11 diseases, including measles and polio, it calls for limiting vaccines for other diseases, like hepatitis A and B and meningococcal disease, to high-risk populations. Photo by Bonnie Cash/UPI | License Photo

Aug. 10 (UPI) — President Donald Trump signed an executive order Monday to reduce the number of vaccines recommended for children.

At the signing of the executive order, Trump shared claims that childhood vaccines are linked to an increase in autism diagnoses without evidence. Health and Human Services Secretary Robert F. Kennedy Jr., who was present for the signing, has maintained this stance as well.

Scientific research into potential links between vaccines and autism have consistently found no connection.

Trump’s executive order also advises breaking up MMR vaccines for the mumps, measles and rubella, a vaccine Trump called “quite lethal,” into three separate vaccines. In the more than 50 years since the MMR vaccine was developed there has been no evidence that it is deadly.

“Nothing bad can happen from what we’re doing,” Trump said.

Vaccine advocates and researchers have warned that reducing the distribution of childhood vaccines will make children more vulnerable to disease. Sen. Bill Cassidy, R-La., who is a medical doctor, posted on social media that the executive order “is wrong.”

“The President does not have the expertise to make these changes,” Cassidy wrote. “Vaccines are overwhelmingly safe. Vaccines are effective. Vaccines DO NOT cause autism. Breaking up vaccines will mean children have to get more shots to get the same protection, not fewer shots. It will increase hesitancy and make children less safe.”

Trump acknowledged the increased burden of breaking up vaccines when addressing reporters after the signing.

“It’s inconvenient. It’s five stops but it’s something that I think will have a huge impact on autism,” Trump said.

Aug. 5 (UPI) — The U.S. Senate voted Wednesday to confirm Dr. Erica Schwartz as the leader of the Centers for Disease Control and Prevention, finally installing a new director for the agency after nearly a year.

Schwartz was deputy surgeon general during President Donald Trump‘s first term. She is a retired U.S. Coast Guard officer and Navy physician.

The vote Wednesday was 51-44, mostly along party lines, NBC News reported. Sen.Tim Kaine, D-Va., voted with Republicans to approve Schwartz.

Schwartz succeeds Dr. Susan Monarez, who was fired by Health Secretary Robert F. Kennedy Jr. in August after less than a month in the job, allegedly because she disagreed with Kennedy about vaccines.

Monarez was followed by several acting directors — first Jim O’Neill, Kennedy’s deputy secretary, and then Dr. Jay Bhattacharya, the director of the National Institutes of Health.

The White House nominated Schwartz to fill the role in April. Kennedy said that he hadn’t spoken to Trump about nominating her.

Schwartz has a background of supporting and guiding vaccination programs for the government. She said at a Senate hearing in July that vaccines are safe and effective, although some health experts said she didn’t do enough to distance herself from some of Kennedy’s views, NBC News reported.

“As CDC director, my sacred responsibility is to provide the American people with public health guidance that is clear, honest and evidence based,” Schwartz said. “I will never betray the science.”

Sen. Bill Cassidy, R-La., chairman of the Health, Education,Labor and Pensions Committee and a medical doctor, criticized Schwartz during the hearing for allegedly dodging his questions.

However, he said he chose to vote for Schwartz on Wednesday after they were able to talk again.

“I am confident that she knows what she is doing and will stand against those who do not,” he said during a committee meeting in July. “If confirmed, I look forward to working with Dr. Schwartz to protect children’s health and regain trust in the CDC. There’s more to do to repair the damage that has been done to the U.S. public health response, but this is a start.”

The National Public Health Coalition, an advocacy group containing many former CDC employees, said last month that it would not support Schwartz’s nomination based on the July hearing.

“The public needed to hear clear commitments about how she would protect CDC guidance from political pressure,” it said in a statement. “Too often, her stated commitments were incomplete, vague or missing.”

July 23 (UPI) — A Senate committee delayed a vote on the Trump administration’s Centers for Disease Control and Prevention director nominee, Erica Schwartz, because enough members were not present.

Sen. Lisa Murkowski, R-Alaska, was absent from the Senate Committee on Health, Education, Labor and Pensions meeting on Thursday because of a family emergency, which led committee chair Bill Cassidy, R-La., to postpone the vote, Politico reported.

Cassidy also said Thursday that he decided to vote for Schwartz because of a “good faith action” the CDC reportedly made to its website earlier in the day.

The action included changing language on its website about the lack of an association between vaccines and autism, which had been ordered changed by Health and Human Services Secretary Robert F. Kennedy Jr. last year.

Cassidy asked detailed questions during her nomination hearing about vaccines and how the agency, which has had a full-time director for just one month since President Donald Trump re-entered the White House, would restore confidence in its public health mission, The Hill reported.

“I’m confident that she knows what she’s doing and will stand against those who do not,” Cassidy said during the meeting.

“If confirmed, I look forward to working with Dr. Schwartz to protect children’s health and regain trust in the CDC,” he said.

“There’s more to do to repair the damage that has been done to the U.S. public health response, but this is a start,” the Louisiana Republican added.

Even with Cassidy deciding to vote for Schwartz, Republicans on the committee would have needed a Democrat or Sen. Bernie Sanders, I-Vt., who caucuses with the Democrats, to vote in favor.

Sanders ended that possibility when he expressed respect for Schwartz’s career but said that he was concerned she would not be able to hold off some of the controversial changes Kennedy has either proposed or forced on the agency.

“I will be voting against Dr. Schwartz because we need people in this country who are going to stand up, protect the American people and I don’t think you can see that right now with Secretary Kennedy in his position,” Sanders said.

The HELP committee’s next executive session is scheduled for July 30, which is also the next time it will consider nominations, making it the next opportunity for Schwartz’s nomination to come up for a vote.

The committee also put off a vote on Sean Kaufman, who is nominated to lead the Administration for Strategic Preparedness and Response, because Republicans did not have enough votes to forward the nomination to the full Senate.

June 10 (UPI) — The American College of Obstetricians and Gynecologists released its recommended maternal vaccine schedule Wednesday, breaking for the first time on advice from the U.S. Center for Disease Control and Prevention.

The group advises four vaccines during pregnancy, including a COVID-19 shot; a flu shot; a tetanus, diphtheria and pertussis (Tdap) vaccine; and a vaccine that protects the fetus against respiratory syncytial virus, commonly called RSV.

“Changing national recommendations coupled with rampant vaccine misinformation are resulting in confusion for both patients and healthcare professionals,” Camille Clare, ACOG president, said in a statement.”It is incredibly important for the public to have access to reliable,evidence-based information on maternal immunizations from a trusted source.”

The schedule also includes additional vaccines for those with certain risk factors and for those postpartum and breastfeeding. Thirteen other medical societies, including the American Academy of Pediatrics, the American Academy of Family Physicians and the American College of Nurse-Midwives, endorsed the list.

The CDC, under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic, changed its recommended maternal vaccine schedule last year, removing the flu and COVID-19 shots, The Hill reported.

In changing the schedule in 2025, the CDC did not its usual process of using a panel of vaccine experts to review studies and make advice. The American Academy of Pediatrics and some U.S. states have also broken with the new CDC guidelines.

“Immunization is an essential part of preventative care forpeople who are pregnant, postpartum and lactating — and for their infants,” ACOG said in its recommendations. “OB-GYNs can reduce the frequency of vaccine-preventable diseases by being aware of current vaccine recommendations, counseling patients to receive appropriate vaccines and integrating vaccination into routine clinical practice.”